Literature DB >> 8405761

Insulin resistance syndrome: possible key role of blood flow in resting muscle.

P O Ganrot1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8405761     DOI： 10.1007/bf00400365

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  47 in total

1.  Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity.

Authors:  M Laakso; S V Edelman; J M Olefsky; G Brechtel; P Wallace; A D Baron
Journal:  Diabetes       Date:  1990-08       Impact factor: 9.461

2.  Microvascular rarefaction and tissue vascular resistance in hypertension.

Authors:  A S Greene; P J Tonellato; J Lui; J H Lombard; A W Cowley
Journal:  Am J Physiol       Date:  1989-01

3.  Reduced erythrocyte deformability in diabetes.

Authors:  D E McMillan; N G Utterback; J La Puma
Journal:  Diabetes       Date:  1978-09       Impact factor: 9.461

Review 4.  Microcirculation and diabetes.

Authors:  J E Tooke
Journal:  Br Med Bull       Date:  1989-01       Impact factor: 4.291

5.  Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.

Authors:  T Pollare; H Lithell; I Selinus; C Berne
Journal:  BMJ       Date:  1989-04-29

6.  Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans.

Authors:  A D Baron; G Brechtel; P Wallace; S V Edelman
Journal:  Am J Physiol       Date:  1988-12

7.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

Authors:  S Lillioja; A A Young; C L Culter; J L Ivy; W G Abbott; J K Zawadzki; H Yki-Järvinen; L Christin; T W Secomb; C Bogardus
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Central and peripheral circulation in relation to muscle-fibre composition in normo- and hyper-tensive man.

Authors:  A Juhlin-Dannfelt; M Frisk-Holmberg; J Karlsson; P Tesch
Journal:  Clin Sci (Lond)       Date:  1979-04       Impact factor: 6.124

10.  Effect of propranolol and prazosin on blood lipids. The Oslo Study.

Authors:  P Leren; P O Foss; A Helgeland; I Hjermann; I Holme; P G Lund-Larsen
Journal:  Lancet       Date:  1980-07-05       Impact factor: 79.321
View more
  6 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  Oxidative stress and insulin action: is there a relationship?

Authors:  G Paolisso; D Giugliano
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

3.  Autonomic dysfunction is related to impaired pancreatic beta cell function in patients with coronary artery disease.

Authors:  J W Sayer; B Marchant; S V Gelding; J A Cooper; A D Timmis
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 4.  Endothelin-1 in the pathophysiology of obesity and insulin resistance.

Authors:  Haley N Jenkins; Osvaldo Rivera-Gonzalez; Yann Gibert; Joshua S Speed
Journal:  Obes Rev       Date:  2020-07-06       Impact factor: 9.213

Review 5.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

6.  Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.

Authors:  M Maccario; S E Oleandri; E Avogadri; R Rossetto; S Grottoli; M Procopio; F Camanni; E Ghigo
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.